Hermetica Superfood Encyclopedia
The Short Answer
PT-141 (Bremelanotide) is a synthetic peptide that activates melanocortin-4 receptors in the hypothalamus to enhance sexual arousal and desire. This FDA-approved medication works through central nervous system pathways rather than vascular mechanisms.
CategoryAmino Acid & Peptide
GroupCompound
Evidence LevelStrong
Primary KeywordPT-141 benefits
Synergy Pairings4
PT-141 (Bremelanotide) — botanical close-up
Health Benefits
Enhances sexual arousal and desire by activating melanocortin receptors in the brain, leading to increased libido. - May improve erectile function in men by promoting nitric oxide release and vascular dilation. - Increases sexual satisfaction and frequency of intimacy, with studies showing up to 50% improvement in responsiveness. - Supports healthy sexual function in women, especially those with hypoactive sexual desire disorder (HSDD). - Reduces sexual performance anxiety by balancing stress-related neurotransmitters. - Stimulates dopamine pathways, elevating mood and pleasure associated with intimacy. - Offers rapid onset of action, with effects often felt within 30-60 minutes. - Can help restore intimacy and confidence in relationships by addressing both psychological and physiological barriers.
Origin & History
Natural habitat
PT-141, also known as Bremelanotide, is a synthetic peptide derived from the melanocortin receptor agonist family. It is produced through chemical synthesis and is primarily used for its potential effects on sexual arousal.
“Developed in the early 2000s, PT-141 was initially researched for tanning effects before its sexual arousal properties were discovered.”Traditional Medicine
Scientific Research
PT-141 has been studied in clinical trials for its effects on sexual arousal and erectile dysfunction, showing promising results. Further studies are ongoing.
Preparation & Dosage
Traditional preparation
Typical dosage is 1.75 mg administered via subcutaneous injection as needed. Consult a healthcare provider before use.
Nutritional Profile
- Composed of a sequence of amino acids.
- Administered via subcutaneous injection.
- Acts on melanocortin receptors in the brain.
How It Works
Mechanism of Action
PT-141 selectively binds to melanocortin-4 (MC4R) and melanocortin-1 (MC1R) receptors in the hypothalamic paraventricular nucleus. This binding activates cyclic adenosine monophosphate (cAMP) signaling pathways that modulate dopaminergic and noradrenergic neurotransmission. The resulting neural cascade enhances sexual motivation and arousal through central nervous system stimulation rather than peripheral vascular effects.
Clinical Evidence
Clinical trials included over 1,200 premenopausal women with hypoactive sexual desire disorder (HSDD). Phase 3 studies showed significant improvements in sexual desire scores on the Female Sexual Function Index, with 25% more participants achieving meaningful increases compared to placebo. Men's studies demonstrated improved erectile function scores by 2-3 points on the International Index of Erectile Function. Evidence quality is strong for women with HSDD, with FDA approval granted in 2019.
Safety & Interactions
Common side effects include nausea (up to 40% of users), flushing, and headache, typically occurring within 2 hours of injection. PT-141 may interact with blood pressure medications due to potential hypotensive effects. Contraindicated in patients with uncontrolled hypertension or cardiovascular disease. Safety during pregnancy and breastfeeding has not been established, and use is not recommended.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
BremelanotideBMTMelanocortin receptor agonistSexual enhancement peptideLibido peptideArousal compound
Frequently Asked Questions
How long does PT-141 take to work?
PT-141 typically begins working within 45 minutes to 2 hours after subcutaneous injection. Peak effects occur around 2-3 hours post-injection and can last up to 24 hours.
What is the typical PT-141 dosage?
The standard PT-141 dose is 1.75 mg administered subcutaneously at least 45 minutes before anticipated sexual activity. Maximum frequency is once every 24 hours, with no more than 8 doses per month recommended.
Can PT-141 be taken with Viagra or Cialis?
PT-141 can potentially be used alongside PDE5 inhibitors like Viagra since it works through different mechanisms (central vs. peripheral). However, combination use should only occur under medical supervision due to potential blood pressure effects.
Does PT-141 work for both men and women?
PT-141 is FDA-approved specifically for premenopausal women with hypoactive sexual desire disorder. While studies show promise in men for erectile dysfunction, it lacks FDA approval for male sexual dysfunction treatment.
Is PT-141 the same as Melanotan II?
PT-141 is a modified version of Melanotan II with reduced melanocortin-1 receptor activity, minimizing skin darkening effects. PT-141 specifically targets sexual function while Melanotan II has broader melanocortin receptor activity affecting skin pigmentation.
What are the potential side effects of PT-141?
Common side effects of PT-141 include nausea, facial flushing, and headaches, which typically subside with continued use or dose adjustment. Some users report temporary changes in skin pigmentation or darkening of moles due to melanocortin receptor activation. Serious side effects are rare but may include changes in blood pressure; discontinue use and consult a healthcare provider if severe reactions occur.
Who should avoid using PT-141?
PT-141 should be avoided by individuals with uncontrolled high blood pressure, active cancer, or a history of skin cancer, as melanocortin activation may affect melanoma risk. Pregnant and breastfeeding women should not use PT-141 due to insufficient safety data. Those with cardiovascular conditions should consult their healthcare provider before use, as the compound affects vascular function.
What does clinical research show about PT-141's effectiveness?
Clinical trials demonstrate that PT-141 significantly improves sexual desire and arousal in both men and women, with FDA approval for female sexual interest/arousal disorder (FSIAD). Studies show effectiveness rates of 40-50% for improving sexual function compared to placebo, with benefits observed within 2-4 weeks of regular use. Research indicates PT-141 works through a distinct mechanism from phosphodiesterase inhibitors, making it suitable for different patient populations.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w pt-141-bremelanotide curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
